AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Comparison of Erector Spinae Plane Block and Caudal Block for Postoperative Analgesia in Pediatric Patients Undergoing Orchiopexy: A Prospective Observational Study

Recruitingn/aAges 1 Year - 7 YearsMaleProf. Dr. Cemil Tascıoglu Education and Research …
💬

In plain words

What the trial is, and whether it could suit you

This study aims to compare the analgesic efficacy of ultrasound-guided erector spinae plane block and caudal block for postoperative pain management in pediatric patients undergoing orchiopexy. Postoperative pain scores, time to first rescue analgesic requirement, total analgesic consumption, and block-related adverse effects will be evaluated during the first 24 hours after surgery. The study will assess whether erector spinae plane block provides effective postoperative analgesia comparable to or superior to caudal block in pediatric orchiopexy.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Children aged 1 to 7 years with ASA physical status I-II undergoing unilateral orchiopexy surgery. Exclusion Criteria: * ASA physical status ≥ III * History of prematurity (gestational age \< 37 weeks) Known coagulation disorders or bleeding tendency * Infection, inflammation, or skin lesion at the injection site * Known neurological or neuromuscular diseases * Presence of significant cardiac or pulmonary disease (e.g., congenital heart disease, active asthma) * Hepatic or renal dysfunction * Known allergy or hypersensitivity to local anesthetics (e.g., bupivacaine, lidocaine) * Developmental delay or cognitive impairment that prevents accurate pain assessment * Use of additional regional analgesia techniques (e.g., caudal block) during surgery * Block failure or intraoperative complications requiring exclusion from protocol analysis * Lack of parental consent for participation in the study
💊

What it tests

  • Not listed
📍

Where

1 site
Prof. Dr Cemil Taşcıoğlu Şehir Hastanesi
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy